Novel Drug Led to Meaningful Weight Loss in Adults With Obesity

(MedPage Today) — Subcutaneous injections of an investigational, selective long-acting amylin receptor agonist led to clinically meaningful reductions in body weight among adults with obesity, a phase II randomized trial showed.
The mean percent…